![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, April 11, 2018 1:31:37 PM
https://www.washingtonpost.com/
https://search.yahoo.com/yhs/search;_ylt=AwrJ3UpIQc5aY04AaTMPxQt.;_ylc=X1MDMjExNDcwMDU1OQRfcgMyBGZyA3locy1wdHktcHR5X2VtYWlsBGdwcmlkAwRuX3JzbHQDMARuX3N1Z2cDMARvcmlnaW4Dc2VhcmNoLnlhaG9vLmNvbQRwb3MDMARwcXN0cgMEcHFzdHJsAzAEcXN0cmwDMTE2BHF1ZXJ5A1dhc2hpbmd0b24lMjBQb3N0JTIwQXByaWwlMjAxMCUyQyUyMDIwMTglMjBDb3JjZXB0JTIwRHJ1ZyUyMGZvciUyMHRyZWF0aW5nJTIwSGFsbHVjaW5hdGlvbnMlMjBIZWFsdGglMjBhbmQlMjBTY2llbmNlBHRfc3RtcAMxNTIzNDY3MjY1?p=Washington+Post+April+10%2C+2018+Corcept+Drug+for+treating+Hallucinations+Health+and+Science&fr2=sb-top&hspart=pty&hsimp=yhs-pty_email¶m1=20180226¶m2=72ec8054-12ad-4efd-98b7-d333742230e3¶m3=email_1.1~US~appfocus1¶m4=g-lp0-bb9~Chrome~Washington+Post+Corcept+Health+and+Science&type=em_appfocus1_cr
Recent CORT News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/05/2024 11:10:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/05/2024 10:56:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/05/2024 10:31:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/02/2024 08:42:32 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/01/2024 05:36:48 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/01/2024 03:26:49 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/29/2024 08:13:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/29/2024 08:10:07 PM
- Corcept Therapeutics Announces Second Quarter Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 07/29/2024 08:05:00 PM
- Corcept Therapeutics to Announce Second Quarter Financial Results, Provide Corporate Update and Host Conference Call • GlobeNewswire Inc. • 07/22/2024 08:05:00 PM
- Corcept Announces Presentation of Results From Prevalence Phase of CATALYST Clinical Trial at American Diabetes Association’s Scientific Sessions • GlobeNewswire Inc. • 06/24/2024 08:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/06/2024 10:21:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/06/2024 01:19:38 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/06/2024 01:15:40 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/06/2024 01:15:01 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/06/2024 01:13:55 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/06/2024 01:11:05 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/06/2024 01:10:05 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/03/2024 06:15:38 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/03/2024 06:05:38 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/03/2024 05:05:50 PM
- Corcept Therapeutics Announces Presentations of Results of Pivotal Phase 3 GRACE Trial Evaluating Relacorilant in Patients with Hypercortisolism (Cushing’s Syndrome) • GlobeNewswire Inc. • 06/03/2024 12:00:00 PM
- Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments • Edgar (US Regulatory) • 05/31/2024 08:47:27 PM
- Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments • Edgar (US Regulatory) • 05/31/2024 08:46:50 PM
- Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments • Edgar (US Regulatory) • 05/31/2024 08:45:49 PM
HealthLynked Corp. Announces Second Quarter and First Half 2024 Results: Continued Cost Reductions Set the Stage for Strategic Shift to App-Based Technology Services • HLYK • Aug 16, 2024 8:00 AM
PickleJar Announces Official Name Change and New Ticker Symbol • NREG • Aug 15, 2024 2:23 PM
VAYK's Q2 Profit Added to Accumulated Net Profit of Over $2.2 Million In 18 Months • VAYK • Aug 15, 2024 9:07 AM
Swifty Global Reports Strong Q2 Performance and Prepares for Major Exchange Uplisting • DRCR • Aug 15, 2024 9:04 AM
Mayback's Global Entertainment Signs Global Distribution Agreement with Children's Media Studio • AHRO • Aug 15, 2024 8:45 AM
POET Technologies Reports Second Quarter 2024 Financial Results • POET • Aug 15, 2024 8:04 AM